Scarica l'app Stockscreener
1.6001
12.07%
0.1501
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$1.45
Aprire:
$1.59
Volume 24 ore:
586.95K
Relative Volume:
5.36
Capitalizzazione di mercato:
$13.62M
Reddito:
-
Utile/perdita netta:
$-23.81M
Rapporto P/E:
-0.5545
EPS:
-2.8859
Flusso di cassa netto:
$-17.01M
1 W Prestazione:
-47.07%
1M Prestazione:
-61.58%
6M Prestazione:
-76.92%
1 anno Prestazione:
-77.60%
Intervallo 1D:
$1.55
$1.80
Intervallo di 1 settimana:
$1.44
$2.90
Portata 52W:
$1.44
$13.48
Cel-Sci Corp. Stock (CVM) Company Profile
Nome
Cel-Sci Corp.
Settore
Industria
Telefono
703-506-9460
Indirizzo
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
1.61 | 12.26M | 0 | -23.81M | -17.01M | -2.8859 |
VRTX
Vertex Pharmaceuticals Inc
|
427.00 | 108.54B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
712.36 | 75.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.30 | 50.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.15 | 40.45B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.24 | 32.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-01-13 | Iniziato | H.C. Wainwright | Buy |
| 2015-03-02 | Iniziato | Dawson James | Buy |
Cel-Sci Corp. Borsa (CVM) Ultime notizie
EDGAR Filing Documents for 0001654954-26-004295 - SEC.gov
CEL-SCI (NYSE: CVM) moves to fund Multikine with $13.7M best efforts stock sale - Stock Titan
CVM - Finviz
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Eom Pharmaceutical Holdings Inc (IMUC) - MSN
CEL-SCI (NYSE: CVM) targets $13.7M to fund Multikine confirmatory trial - Stock Titan
Insider Sell: Does CEL SCI Corporation stock have upside surprise potential2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
How does macroeconomics affect Cel-Sci (CVM) Stock | Price at $4.23, Down 2.08%Market Hype - Xã Vĩnh Công
INMB.O PE Ratio & Valuation, Is INMB.O Overvalued - Intellectia AI
XCUR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CVM Technical Analysis & Stock Price Forecast - Intellectia AI
[Form 4] CEL SCI CORP Insider Trading Activity - Stock Titan
CEL-SCI (CVM) CFO awarded 1,336 Common Stock shares in Form 4 filing - Stock Titan
CEL SCI (CVM) CEO awarded 1,682 shares of common stock - Stock Titan
CEO Moves: Is CEL SCI Corporation stock undervalued right nowTrade Risk Summary & Weekly High Momentum Picks - baoquankhu1.vn
If You Invested $1,000 in Adicet Bio Inc (ACET) - Stock Titan
If You Invested $1,000 in CEL-SCI Corp (CVM) - Stock Titan
Trading Action: Is CEL SCI Corporation a strong candidate for buy and hold2026 Snapshot & Entry Point Confirmation Signals - baoquankhu1.vn
Why did CVM shares rally over 7% today? - MSN
CVM PE Ratio & Valuation, Is CVM Overvalued - Intellectia AI
CEL-SCI's Multikine Therapy Nears Critical Regulatory Milestones () - aktiencheck.de
Volume Recap: Is Regencell Bioscience Holdings Limited stock a smart retirement pickJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Why DID CVM Shares Rally Over 7% Today? - Stocktwits
Cel-Sci (CVM) Reports Narrower Q1 Net Loss - GuruFocus
CEL-SCI Reports Fiscal First Quarter 2026 Results - Investing News Network
Cancer therapy lifted 5-year survival to 73% in trial; next test in 2026 - Stock Titan
Cel-Sci: Fiscal Q1 Earnings Snapshot - kens5.com
Cel-Sci: Overview of First Fiscal Quarter Financial Results - Bitget
CEL SCI CORP SEC 10-Q Report - TradingView
Big Money Moves: Does CEL SCI Corporation stock have upside surprise potential - baoquankhu1.vn
Investment Review: Is CEL SCI Corporation trading at a discountJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
IPO Launch: Is CEL SCI Corporation trading at a discountWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.9% – Should You Sell? - Defense World
Kersten Geert buys Cel Sci (CVM) shares worth $200000 By Investing.com - Investing.com Australia
Insider Buying: Geert Kersten Acquires Additional Shares of CEL-SCI Corp (CVM) - GuruFocus
Kersten Geert buys Cel Sci (CVM) shares worth $200000 - Investing.com
Profit Recap: Does CEL SCI Corporation stock have upside surprise potentialWeekly Investment Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Cel Sci (CVM) Options Delisting Set for January 20th - GuruFocus
Surprises Report: Why CEL SCI Corporation stock could outperform in 2025M&A Rumor & AI Enhanced Trading Alerts - Bộ Nội Vụ
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.5% – What’s Next? - Defense World
Cel-Sci Corporation (CVM) Investor Outlook: Exploring A Potential 625% Upside - DirectorsTalk Interviews
Is CEL SCI Corporation stock dividend yield sustainable2025 Geopolitical Influence & Long-Term Safe Investment Ideas - Улправда
Is CEL SCI Corporation stock positioned well for digital economyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Cel-sci-sci Corp : Dutton Associates Announces Investment Opinion - marketscreener.com
Cel-Sci Corp. Azioni (CVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.78%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):